-
2020 - 01 - 27
Helsinn Grants Exclusive Licensing Rights to Berlin-Chemie Menarini, for ONICIT<sup>®</sup>/ALOXI<sup>®</sup> and AKYNZEO<sup>®</sup> in Russia and CIS region
-
2020 - 03 - 09
Farmindustria's Campaign for Covid-19
-
2020 - 03 - 16
Covid-19: Menarini Group converts production plant to produce and donate disinfectant gel
-
2020 - 04 - 02
COVID-19 Menarini Diagnostics: kit for diagnosis in 20 minutes
-
2020 - 04 - 25
COVID-19: Menarini continues with further donations and reaches a record production of 100 tonnes of disinfectant gel
-
2020 - 04 - 29
Menarini Silicon Biosystems Explores New Application for Circulating Endothelial Cells in COVID-19
-
2020 - 05 - 04
Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million
-
2020 - 05 - 14
25th EHA Congress: Menarini Ricerche discloses first results from the clinical study on SEL24/MEN1703
-
2020 - 06 - 05
Menarini invests 150 million euros in a new pharmaceutical plant in Italy
-
2020 - 06 - 10
Menarini Group Completes Acquisition of Stemline Therapeutics
-
2020 - 06 - 10
Menarini Group Completes a Solid Year of Operating Performance
-
2020 - 06 - 25
Continuous blood glucose monitoring: the Menarini Diagnostics digital “patch” now available!
-
2020 - 07 - 02
Menarini Ricerche Announces C-PRECISE-01, a New Phase Ib/II Trial of MEN1611 in Colorectal Cancer
-
2020 - 07 - 09
Menarini Ricerche Announces the Latest Findings of its Vaborem™ and Quofenix™ Clinical Studies
-
2020 - 07 - 23
Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant
-
2020 - 09 - 01
Announced the xxiv edition of the international fair play Menarini award
-
2020 - 09 - 11
International Fair Play Menarini award 2020
-
2020 - 09 - 16
Menarini Ricerche Announces Initiation of Cohort Expansion for the Clinical Study of SEL24/MEN1703 in Acute Myeloid Leukemia
-
2020 - 09 - 17
Menarini Ricerche Announces Dose Escalation Results Of The Clinical Trial Of Men1611 In Breast Cancer
-
2020 - 09 - 25
Radius health & Menarini group provide elacestrant update
-
2020 - 10 - 26
Press release
-
2020 - 10 - 26
Menarini Group: committed to fighting today's covid-19 pandemic with an eye to averting similar health crises in the future
-
2020 - 11 - 06
Menarini against cancer: for a child, ‘home’ means family
-
2020 - 11 - 13
Chmp adopted positive opinion for elzonris (tagraxofusp), for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
-
2020 - 12 - 01
Menarini Ricerche Announces SEL24/MEN1703 Pharmacodynamic Data from the Dose Escalation Part of DIAMOND-01 Trial
-
2020 - 12 - 07
Menarini Announces Results from New Preclinical Studies on MEN1611 for the Treatment of Breast Cancer at the 2020 San Antonio Breast Cancer Symposium
-
2020 - 12 - 16
Menarini Group awarded the coveted XV Transatlantic Award from American Chamber of Commerce in Italy
